Skip to main content
Figure 5 | Stem Cell Research & Therapy

Figure 5

From: Improving outcomes of acute kidney injury using mouse renal progenitor cells alone or in combination with erythropoietin or suramin

Figure 5

Expression of GFP, CD34, and E-cadherin in consecutive sections of the kidney at day 7 after I/R injury. The positive area in MRPC/EPO, MRPC/suramin group MRPC/EPO decreased, while the positive area in MRPC group was still widely distributed. (Magnification 200×). EPO, erythropoietin; I/R, ischemia/reperfusion; MRPC, mouse renal progenital cells.

Back to article page